MapLight Therapeutics Inc
MPLT17.707USD
+0.727+4.28%
交易中 （美东）报价延迟15分钟
733.58M总市值
亏损市盈率 TTM
关于 公司
MapLight Therapeutics Inc简介
公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -
MapLight Therapeutics Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
253.91K
-42099.00%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
248.50K
-22050.00%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
38.10K
-44616.00%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
17.81K
-33382.00%
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
9.48K
+9478.00%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
Dr. Christopher A. Kroeger, M.D.
Dr. Christopher A. Kroeger, M.D.
Co-Founder, President, Chief Executive Officer, Director
Co-Founder, President, Chief Executive Officer, Director
--
--
Mr. James Lillie, Ph.D.
Mr. James Lillie, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Kristopher L. Hanson
Mr. Kristopher L. Hanson
General Counsel
General Counsel
--
--
Ms. Nanna Luneborg, Ph.D.
Ms. Nanna Luneborg, Ph.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Anatol Kreitzer, Ph.D.
Dr. Anatol Kreitzer, Ph.D.
Chief Discovery Officer
Chief Discovery Officer
253.91K
-42099.00%
Mr. Jonathan Gillis, CPA
Mr. Jonathan Gillis, CPA
Chief Accounting Officer, Chief Administrative Officer
Chief Accounting Officer, Chief Administrative Officer
248.50K
-22050.00%
Ms. Erin Pennock Foff, M.D., Ph.D.
Ms. Erin Pennock Foff, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
38.10K
-44616.00%
Mr. Vishwas Setia
Mr. Vishwas Setia
Chief Financial Officer
Chief Financial Officer
17.81K
-33382.00%
Dr. Timothy Garnett
Dr. Timothy Garnett
Independent Director
Independent Director
9.48K
+9478.00%
Mr. Robert Malenka, M.D., Ph.D.
Mr. Robert Malenka, M.D., Ph.D.
Director
Director
--
--
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 2月8日 周日
更新时间: 2月8日 周日
持股股东
股东类型
持股股东
持股股东
占比
Catalyst4 Inc
43.41%
Novo Holdings A/S
8.13%
T. Rowe Price Investment Management, Inc.
4.03%
Forbion Growth Opportunities Fund III Cooperatief UA
3.14%
The Vanguard Group, Inc.
1.92%
其他
39.37%
持股股东
持股股东
占比
Catalyst4 Inc
43.41%
Novo Holdings A/S
8.13%
T. Rowe Price Investment Management, Inc.
4.03%
Forbion Growth Opportunities Fund III Cooperatief UA
3.14%
The Vanguard Group, Inc.
1.92%
其他
39.37%
股东类型
持股股东
占比
Corporation
46.56%
Venture Capital
8.13%
Investment Advisor
7.72%
Individual Investor
3.19%
Investment Advisor/Hedge Fund
0.92%
Insurance Company
0.01%
Sovereign Wealth Fund
0.01%
其他
33.47%
机构持股
更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
4
3.81M
0.06%
--
2025Q4
25
7.61M
16.77%
+7.34M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Catalyst4 Inc
19.70M
43.41%
+19.70M
--
Oct 28, 2025
Novo Holdings A/S
3.69M
8.13%
+3.69M
--
Oct 28, 2025
T. Rowe Price Investment Management, Inc.
11.80K
0.03%
+1.04K
+9.68%
Dec 31, 2025
Forbion Growth Opportunities Fund III Cooperatief UA
1.43M
3.14%
+1.43M
--
Oct 27, 2025
The Vanguard Group, Inc.
44.63K
0.1%
+23.86K
+114.87%
Nov 30, 2025
Lillie (James Woodruff)
336.19K
0.74%
+336.19K
--
Oct 27, 2025
Kreitzer (Anatol)
296.01K
0.65%
+296.01K
--
Oct 27, 2025
Kroeger (Christopher A. M.D.)
457.31K
1.01%
+457.31K
--
Oct 28, 2025
Gillis (Jonathan)
270.55K
0.6%
+270.55K
--
Oct 27, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
